alexa Analgesic properties of fluproquazone
Microbiology

Microbiology

Journal of Chemical Biology & Therapeutics

Author(s): Wheatley D

Abstract Share this page

Fluproquazone, a new analgesic, was compared to a dextropropoxyphene hydrochloride and paracetamol combination (Cosalgesic) in a single blind trial lasting for five days. The trial included cases of various soft-tissue lesions and osteoarthrosis. Treatment was given to 170 patients, 84 of whom received fluproquazone and 86 the combination analgesic. The patients themselves made daily records of the severity of pain on a 100 mm visual analogue scale and in both treatment groups there was highly significant relief of pain, but with no significant differences between them. However, the incidence of side-effects was significantly higher with dextropropoxyphene hydrochloride-paracetamol (30%) than with fluproquazone (9%).

This article was published in RheumatolRehabil and referenced in Journal of Chemical Biology & Therapeutics

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords